Top Employee Participation Stories
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
By Alan GoforthAs Eli Lilly and Novo Nordisk are scrambling to meet demand for their popular weight-loss drugs, Bristol-Myers Squibb is the latest drugmaker to wield the restructuring ax, with plans to cut $1.5 billion in costs by the end of 2025.










